Member of Tentamus - Visit Tentamus.com

Welcome to MicroMol

Microbiology

Your platform for classical pharmaceutical microbiology, testing of bacterial cell banks, bacteriophage analytics, pyrogen testing, examination of live biotherapeutic products and genotoxicity- GMP compliant/ISO 17025 accredited … more

Bioanalytics

Your platform for functional characterization and analysis of your biomolecules combining biochemical, molecular biological, immunological, and cell biological expertise. Ranging from standard techniques, analyzing clinical samples to custom developed bioassays. GMP compliant/ISO 17025 accredited.
… more

Biological Safety / Biocompatibility

Our platform for biocompatibility testing of medical devices according to ISO 10993 and biological safety of pharmaceuticals, biologicals, and biological active substances using in-vitro based test systems and sensitive testing systemsfor detection of contaminants.  GMP-compliant/ISO 17025 accredited
… more

MicroMol Karlsruhe –

A Tentamus company

Micromol was founded in 1996. During the last two decades MicroMol positioned itself as a reliable analytical service provider: GMP compliant and ISO 17025 accredited

In 2017 MicroMol joined the TENTAMUS Laboratory Group represented at over 50 locations worldwide. Together with our partners within the Tentamus network MicroMol can guarantee the highest degree of reliability and quality to its clients.

MicroMol is your dependable service provider combining our state-of-the-art analytical equipment together with the knowledge and experience of our experts, divided in three main analytical departments.

Our mission is to provide individual support, quick response times,  technical expertise combined with the highest quality standards.
We look forward discussing your inquiry and finding the best solution for your needs !

Lates News

Tentamus Group acquires majority stake in Megsan Labs

Berlin (Germany)/ Hyderabad (India), June 24th 2019 Tentamus Group today announced that it has acquired a majority stake in the leading analytical testing services company to pharmaceutical companies, Megsan Labs (in Hyderabad, India). The acquisition is part of Tentamus’ plan to broaden its portfolio of services that support pharmaceutical and biotech customers globally and expand across ... Continued

Draft Guidance for Industry: Mitigation Strategies to Protect Food Against Intentional Adulteration – IA Rule Next Compliance date is July 26, 2019

This draft guidance is being distributed for comment purposes only; submit comments by 07/05/2019 (https://www.regulations.gov/document?D=FDA-2018-D-1398-0025). FSMA’s Mitigation Strategies to Protect Food Against Intentional Adulteration (IA Rule) requires both domestic and foreign companies that are required to register with the FDA to develop strategies that prevent intentional adulteration of food. Depending on business size, compliance dates ... Continued

FDA Draft Guidance - Initiation of Voluntary Recalls

This draft guidance is being distributed for comment purposes only; submit comments by 06/24/2019 (https://www.regulations.gov/document?D=FDA-2018-D-2074-0001). Under 21 CFR 7, subpart C, the FDA lists guidance on policy, procedures, and industry responsibilities for recalls and product correction for voluntary recalls of products subject to FDA’s jurisdiction. The finalized draft guidance will help both industry and the ... Continued

11th World Conference on Biosimilars and Biologics

May 2019: Dr. Markus Fido, CEO of VelaLabs, was one of the keynote speakers at the “11th World Conference on Biosimilars and Biologics” in Miami, USA. The “11th World Conference on Biosimilars and Biologics” has taken place in Miami, USA at May 20-21. The biosimilar conference is an international platform to discuss discoveries, new developments, ... Continued

Tentamus laboratories in your vicinity